Reveal unique insights into the immune response to SARS-CoV-2 not possible using standard antibody tests

30 Nov, 2020 | Newsletters
Reveal unique insights into the immune response to SARS-CoV-2 not possible using standard antibody tests
BBC showcases Fluidic Analytics’ clinical collaboration with Prof Aguzzi – A game-changer in the fight against COVID-19
This report takes you to the frontline in the battle against COVID-19 to see how the researchers at Fluidic Analytics (pioneers of the Fluidity One-W) and University Hospital Zurich are investigating Microfluidic Diffusional Sizing (MDS), a new way to study protein-protein interactions. 

The collaboration involved a 40-patient study to reveal unique insights into the immune response to SARS-CoV-2 that could not be revealed by standard antibody tests. These insights included identifying the presence or absence of neutralising antibodies in a rapid two-hour assay and quantifying the affinity of patient antibodies to key epitopes of the virus directly in minimally diluted serum on the Fluidity One-W Serum.
WATCH THE FULL COVERAGE – CLICK HERE  
If you’re interested, we’d love to offer you a demonstration of the Fluidity One-W so you can see it’s full capabilities in action. 
CONTACT US – CLICK HERE
   
Affinity-based SARS-CoV-2 Surrogate Virus Neutralisation Test  

This User Guide describes an affinity-based receptor competition assays to detect virus-neutralizing antibodies (NAbs) directly in COVID-19 patient serum samples by use of the Fluidity One-W Serum instrument.
DOWNLOAD NOW  

SARS-CoV-2 Antibody Profiling User Guide  

This user guide describes affinity-based antibody profiling against the SARS‑CoV‑2 receptor binding domain (RBD) protein directly in COVID‑19 patient serum samples by use of the Fuidity One‑W Serum instrument.
DOWNLOAD NOW  

Microfluidic Diffusional Sizing (MDS) – How it works  

Microfluidic Diffusional Sizing (MDS)
Offers a new way to study protein interactions in crude biological backgrounds (e.g. cell lysates or blood plasma) and interactions of proteins with other secondary binding partners, like lipids and DNA. 
WATCH NOW    


ATA Scientific has developed a COVID-19 Customer Response Plan to help those that require analytical testing services adapted to the remote working environment.
 Our technical support and service team is ready to support you remotely with web-based demonstrations, online operator training, service support, contract sample testing and instrument hire.
Click here to read more